$5650 | Single User
$6650 | Multi User
$8150 | Corporate License
$10000 | Enterprise License

Women's Health Diagnostics Market by Application (Prenatal Testing, Down Syndrome, HPV, Fertility Test, Pregnancy Test, Urinary Tract Infections, Osteoporosis, Breast, Cervical and Ovarian Cancer Test) End User (Hospitals, Home Care) - Forecast to 2021
[Published by MarketsandMarkets]

Published by MarketsandMarkets: 25 Nov 2016 | 25799 | In Stock
Related Topics: Abbott , Cancer , Fertility , Healthcare , Osteoporosis , Ovarian Cancer , Roche , Women's Health

Introduction

Women's Health Diagnostics Market by Application (Prenatal Testing, Down Syndrome, HPV, Fertility Test, Pregnancy Test, Urinary Tract Infections, Osteoporosis, Breast, Cervical and Ovarian Cancer Test) End User (Hospitals, Home Care) - Forecast to 2021

The global women’s health diagnostics market is projected to reach USD 36.64 billion by 2021, growing at a CAGR of around 7.9% during the forecast period. Growth in this market can be attributed to a number of factors such as high prevalence of infectious diseases in women, rising incidence of chronic and lifestyle-related disorders and increasing awareness about fertility testing in women and initiatives taken by government and health organizations. Moreover, the increasing adoption of point-of-care diagnostic testing and the increasing number of diagnostic and imaging centers are also expected to play a major role in market growth. However, high cost of diagnostic solutions and lack of trained laboratory technicians are some of the factors restraining the growth of this market.

The women health diagnostics market in this report is segmented by application and end users. Based on application, the market is segmented into osteoporosis testing, ovarian cancer testing, cervical cancer testing, breast cancer testing, pregnancy & ovulation testing, prenatal genetic screening & carrier testing, infectious disease testing, sexually transmitted disease (STD) testing, and ultrasound. The osteoporosis segment is further divided into bone densitometry and in vitro blood tests. The ovarian cancer segment is divided into tumor marker tests, diagnostic imaging tests and others. The cervical cancer segment is sub segmented into PAP smear testing and HPV testing. The breast cancer testing segment is further divided into mammography systems, tumor marker tests, blood chemistries & blood cell count tests, biopsies, and other diagnostic imaging tests. Pregnancy and fertility testing market is sub segmented into lab-based testing, pregnancy self-test and ovulation prediction kits, ovulation prediction kits, fertility monitors and thermometers. The prenatal genetic screening & carrier testing segment is further divided into cystic fibrosis, Down syndrome and Edward syndrome, TORCH infections and others (fragile x-syndrome & tay-sachs diseases). Further on, the infectious disease testing market segment is sub segmented into methicillin-resistant staphylococcus aurea (MRSA), urinary tract infections (vaginal pH & vaginitis), hepatitis, tuberculosis and streptococcus testing. The sexually transmitted disease testing segment comprises Chlamydia Trachomatis and Neisseria Gonorrohoeae testing, HIV testing and other STD testing. The ultrasound segment covers breast imaging and ob/gyn imaging. In 2015, the breast cancer testing product segment accounted for the largest share of the women health diagnostics market. This market is primarily driven by the increasing incidence of breast cancer and rising awareness about advanced breast cancer diagnostic techniques. Based on end user, the women health diagnostics market is segmented into three segments, namely, hospitals & clinics, home care, and diagnostic & imaging centers.

In 2015, North America accounted for the largest share to the global women health diagnostics market, followed by Europe, Asia-Pacific, and the RoW. Growth in the North American market is largely driven by the increasing prevalence of cancer among women in this region, the presence of a large number of players and their increasing efforts to expand presence in North America. Furthermore, the increasing prevalence of cancer among women and increasing demand for fertility testing kits and monitors in North American countries is augmenting the demand for diagnostic tests.

Some of the major players in the women health diagnostics market are Siemens AG (Germany), Quest Diagnostics Inc. (U.S.), Hologic, Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland), PerkinElmer Inc. (U.S.), Alere Inc. (U.S.), GE Healthcare (U.S.), Becton, Dickinson and Company (BD) (U.S.), Abbott Laboratories (U.S.), bioMérieux SA (France), and Koninklijke Philips N.V. (Netherlands).

Research Coverage

 Detailed insights on all the submarkets, based on application (osteoporosis testing, ovarian cancer testing, cervical cancer testing, breast cancer testing, pregnancy & ovulation testing, prenatal genetic screening & carrier testing, infectious disease testing, sexually transmitted disease testing, and ultrasound), this can help market players to identify high growth segments in the women’s health diagnostics market.

 The report also provides information on key players in this market and their growth strategies and recent developments. This can help the company to assess the competition at global and regional levels in a better manner.

 Key insights and market sizing for the different end users of the women health diagnostics market namely, hospitals & clinics, home healthcare, and diagnostic & imaging centers.

 Country-wise market size and forecast for all the sub segments. Thus, not only the high growth application and end user areas; the market size numbers provided in the report will also enable market players to identify key geographic markets, and thereby strategize global marketing efforts in order to achieve sustainable revenue growth in the coming years.

 It provides key insights on market dynamics, such as drivers, restraints, opportunities, and challenges for this market.

Reasons to Buy the Report

The report will augment established firms as well as new entrants/smaller firms to measure the pulse of the market, which in turn would help them garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for increasing their market shares.

This report provides insights on the following pointers:

• Market Penetration: Comprehensive information on product portfolios offered by top players in the women health diagnostics market. The report analyzes the women’s health diagnostics market by application, and end user across all regions

• Product Development/Innovation: Detailed insights on upcoming trends, research and development activities, and new product launches in the women health diagnostics market

• Market Development: Comprehensive information on the lucrative emerging markets by application, end user, and region

• Market Diversification: Exhaustive information of new products, growing regions, recent developments, and investments in the women health diagnostics market.

• Competitive Assessment: In-depth assessment of market shares, growth strategies, products, and distribution networks, of leading players in the women health diagnostics market

Table of Contents
for Women's Health Diagnostics Market by Application (Prenatal Testing, Down Syndrome, HPV, Fertility Test, Pregnancy Test, Urinary Tract Infections, Osteoporosis, Breast, Cervical and Ovarian Cancer Test) End User (Hospitals, Home Care) - Forecast to 2021 [Published by MarketsandMarkets]

  • TABLE OF CONTENTS

    1 INTRODUCTION 22

    1.1 OBJECTIVES OF THE STUDY 22

    1.2 MARKET DEFINITION 22

    1.3 MARKET SCOPE 23

    1.3.1 MARKETS COVERED 23

    1.3.2 YEARS CONSIDERED FOR THE STUDY 24

    1.4 CURRENCY 25

    1.5 LIMITATIONS 25

    1.6 STAKEHOLDERS 25

    2 RESEARCH METHODOLOGY 26

    2.1 RESEARCH DATA 26

    2.1.1 SECONDARY DATA 27

    2.1.1.1 Key data from secondary sources 27

    2.1.2 PRIMARY DATA 28

    2.1.2.1 Key data from primary sources 28

    2.1.2.2 Key industry insights 29

    2.2 MARKET SIZE ESTIMATION 30

    2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 32

    2.4 MARKET SHARE ESTIMATION 33

    2.5 ASSUMPTIONS FOR THE STUDY 33

    3 EXECUTIVE SUMMARY 34

    4 PREMIUM INSIGHTS 37

    4.1 WOMEN’S HEALTH DIAGNOSTICS: MARKET OVERVIEW 37

    4.2 ASIA-PACIFIC: PREGNANCY AND FERTILITY TESTING MARKET, BY PRODUCT TYPE (2015) 38

    4.3 GEOGRAPHIC SNAPSHOT OF THE WOMEN’S HEALTH DIAGNOSTICS MARKET 39

    4.4 GEOGRAPGIC MIX: WOMEN’S HEALTH DIAGNOSTICS MARKET 40

    4.5 WOMEN’S HEALTH DIAGNOSTICS MARKET: DEVELOPED VS. DEVELOPING MARKETS 41

    5 MARKET OVERVIEW 42

    5.1 INTRODUCTION 43

    5.2 KEY MARKET DYNAMICS 44

    5.2.1 KEY MARKET DRIVERS 45

    5.2.1.1 High prevalence of infectious diseases in women 45

    5.2.1.2 Rising incidence of chronic and lifestyle-related disorders in women 45

    5.2.1.3 Increasing awareness about fertility testing in women and initiatives taken by government and health organizations 46

    5.2.1.4 Increased adoption of point-of-care and rapid diagnostic tests 47

    5.2.1.5 Growth in the number of private diagnostic and imaging centers 47

    5.2.1.6 Public-private partnerships to enhance the infrastructure of diagnostic imaging centers 48

    5.2.2 KEY MARKET RESTRAINTS 49

    5.2.2.1 High cost of diagnostic imaging systems and procedures 49

    5.2.2.2 Shortage of skilled laboratory technicians 49

    5.2.3 KEY MARKET OPPORTUNITIES 50

    5.2.3.1 Improving healthcare infrastructure in emerging markets 50

    5.2.3.2 Growing number of regulatory approvals for immunoassay diagnostic techniques 51

    5.2.4 KEY MARKET CHALLENGES 52

    5.2.4.1 Stringent regulatory guidelines 52

    5.2.4.2 Increasing adoption of refurbished diagnostic imaging systems 52

    6 INDUSTRY INSIGHTS 53

    6.1 INTRODUCTION 53

    6.2 INDUSTRY TRENDS 54

    6.2.1 GROWING FOCUS ON MICROFLUIDICS- AND NANOTECHNOLOGY-BASED POC DEVICES FOR DIAGNOSTICS 54

    6.2.1.1 Microfluidics-based lab-on-a-chip (LOC) devices for laboratory testing 54

    6.2.1.2 Evolution of paper-based microfluidic POC diagnostic devices 54

    6.2.2 RISING FOCUS OF MARKET PLAYERS ON PREGNANCY AND FERTILITY ISSUES IN EMERGING REGIONS 55

    6.3 CLINICAL TRIALS ASSESSMENT FOR BREAST CANCER DIAGNOSTICS 56

    7 WOMEN’S HEALTH DIAGNOSTICS MARKET, BY APPLICATION 58

    7.1 INTRODUCTION 59

    7.2 OSTEOPOROSIS TESTING 61

    7.2.1 BONE DENSITOMETRY 62

    7.2.2 IN VITRO BLOOD TESTS 63

    7.3 BREAST CANCER TESTING 64

    7.3.1 MAMMOGRAPHY 67

    7.3.2 BREAST CANCER TUMOR MARKER TESTS 68

    7.3.3 BLOOD CHEMISTRIES AND BLOOD CELL COUNT TESTS 69

    7.3.4 BIOPSIES 70

    7.3.5 OTHER DIAGNOSTIC IMAGING TESTS 71

    7.4 OVARIAN CANCER TESTING 72

    7.4.1 OVARIAN CANCER TUMOR MARKER TESTS 73

    7.4.2 DIAGNOSTIC IMAGING TESTS 75

    7.4.3 OTHER TESTS 76

    7.5 CERVICAL CANCER TESTING 77

    7.5.1 PAP SMEAR 78

    7.5.2 HPV TESTING 79

    7.6 PREGNANCY AND FERTILITY TESTING 80

    7.6.1 LAB-BASED TESTING 82

    7.6.2 PREGNANCY TESTING AND OVULATION PREDICTION KITS 83

    7.6.3 FERTILITY MONITORS 84

    7.7 PRENATAL GENETIC SCREENING AND CARRIER TESTING 85

    7.7.1 CYSTIC FIBROSIS 87

    7.7.2 DOWN SYNDROME AND EDWARDS SYNDROME 88

    7.7.3 TORCH INFECTIONS 89

    7.7.4 OTHER DISEASES 90

    7.8 INFECTIOUS DISEASE TESTING 91

    7.8.1 MRSA TESTING 93

    7.8.2 URINARY TRACT INFECTION TESTING (VAGINAL PH & VAGINITIS) 94

    7.8.3 HEPATITIS TESTING 95

    7.8.4 TUBERCULOSIS TESTING 96

    7.8.5 OTHER INFECTIOUS DISEASES 98

    7.9 SEXUALLY TRANSMITTED DISEASE TESTING 99

    7.9.1 CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE (CT/NG) TESTING 100

    7.9.2 HIV TESTING 101

    7.9.3 OTHER SEXUALLY TRANSMITTED DISEASES 103

    7.10 ULTRASOUND TESTS 104

    7.10.1 BREAST IMAGING 105

    7.10.2 OB/GYN IMAGING 106

    8 WOMEN’S HEALTH DIAGNOSTICS MARKET, BY END USER 108

    8.1 INTRODUCTION 109

    8.2 HOSPITALS AND CLINICS 110

    8.3 DIAGNOSTIC AND IMAGING CENTERS 112

    8.4 HOME CARE 113

    9 WOMEN’S HEALTH DIAGNOSTICS MARKET, BY REGION 115

    9.1 INTRODUCTION 116

    9.2 NORTH AMERICA 117

    9.2.1 U.S. 125

    9.2.2 CANADA 131

    9.3 EUROPE 137

    9.3.1 GERMANY 145

    9.3.2 U.K. 151

    9.3.3 FRANCE 157

    9.3.4 ITALY 163

    9.3.5 SPAIN 169

    9.3.6 REST OF EUROPE 175

    9.4 ASIA-PACIFIC 181

    9.4.1 JAPAN 189

    9.4.2 CHINA 195

    9.4.3 INDIA 201

    9.4.4 REST OF ASIA-PACIFIC 207

    9.5 ROW 213

    9.5.1 LATIN AMERICA 219

    9.5.2 MIDDLE EAST & AFRICA 225

    10 COMPETITIVE LANDSCAPE 232

    10.1 OVERVIEW 232

    10.2 STRATEGIC BENCHMARKING 233

    10.3 COMPETITIVE SITUATIONS AND TRENDS 236

    10.3.1 PRODUCT LAUNCHES 237

    10.3.2 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS 238

    10.3.3 ACQUISITIONS 239

    10.3.4 REGULATORY APPROVALS 240

    11 COMPANY PROFILES 241

    (Overview, Products and Services, Financials, Strategy & Development)*

    11.1 SIEMENS AG 241

    11.2 QUEST DIAGNOSTICS INC. 245

    11.3 HOLOGIC, INC. 253

    11.4 F. HOFFMANN-LA ROCHE AG 258

    11.5 PERKINELMER INC. 262

    11.6 ALERE INC. 264

    11.7 GE HEALTHCARE 266

    11.8 BECTON, DICKINSON AND COMPANY 269

    11.9 ABBOTT LABORATORIES 271

    11.10 BIOMÉRIEUX SA 274

    11.11 KONINKLIJKE PHILIPS N.V. 276

    *Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies.

    12 APPENDIX 279

    12.1 INSIGHTS OF INDUSTRY EXPERTS 279

    12.2 DISCUSSION GUIDE 280

    12.3 OTHER DEVELOPMENTS 285

    12.4 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 288

    12.5 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 290

    12.6 AVAILABLE CUSTOMIZATIONS 291

    12.7 RELATED REPORTS 292

List Of Tables
in Women's Health Diagnostics Market by Application (Prenatal Testing, Down Syndrome, HPV, Fertility Test, Pregnancy Test, Urinary Tract Infections, Osteoporosis, Breast, Cervical and Ovarian Cancer Test) End User (Hospitals, Home Care) - Forecast to 2021 [Published by MarketsandMarkets]

LIST OF TABLES


TABLE 1 RISING INCIDENCE OF CHRONIC AND LIFESTYLE-RELATED DISORDERS IN WOMEN TO DRIVE MARKET GROWTH 48

TABLE 2 HIGH COST OF DIAGNOSTIC IMAGING SYSTEMS AND PROCEDURES AFFECTING THE RATE OF ADOPTION IN EMERGING MARKETS 50

TABLE 3 IMPROVING HEALTHCARE INFRASTRUCTURE IN EMERGING MARKETS TO PLAY A MAJOR ROLE IN THE GROWTH OF THE WOMEN’S HEALTH DIAGNOSTICS MARKET 51

TABLE 4 STRINGENT REGULATORY GUIDELINES POSE A CHALLENGE FOR DIAGNOSTIC DEVICE MANUFACTURERS 52

TABLE 5 WOMEN’S HEALTH DIAGNOSTICS MARKET: PRODUCT PORTFOLIO ANALYSIS 59

TABLE 6 GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION,

2014-2021 (USD MILLION) 60

TABLE 7 GLOBAL OSTEOPOROSIS TESTING MARKET SIZE, BY TYPE,

2014-2021 (USD MILLION) 61

TABLE 8 GLOBAL OSTEOPOROSIS TESTING MARKET SIZE, BY COUNTRY,

2014-2021 (USD MILLION) 62

TABLE 9 GLOBAL BONE DENSITOMETRY MARKET SIZE, BY COUNTRY,

2014-2021 (USD MILLION) 63

TABLE 10 GLOBAL IN VITRO BLOOD TESTS MARKET SIZE, BY COUNTRY,

2014-2021 (USD MILLION) 64

TABLE 11 GLOBAL BREAST CANCER TESTING MARKET SIZE, BY TYPE,

2014-2021 (USD MILLION) 66

TABLE 12 GLOBAL BREAST CANCER TESTING MARKET SIZE, BY COUNTRY,

2014-2021 (USD MILLION) 66

TABLE 13 GLOBAL MAMMOGRAPHY SYSTEMS MARKET SIZE, BY COUNTRY,

2014-2021 (USD MILLION) 67

TABLE 14 GLOBAL BREAST CANCER TUMOR MARKER TESTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION) 68

TABLE 15 GLOBAL BLOOD CHEMISTRIES AND BLOOD CELL COUNT TESTS MARKET SIZE,

BY COUNTRY, 2014-2021 (USD MILLION) 69

TABLE 16 GLOBAL BIOPSIES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION) 70

TABLE 17 GLOBAL OTHER DIAGNOSTIC IMAGING TESTS MARKET SIZE, BY COUNTRY,

2014-2021 (USD MILLION) 71

TABLE 18 GLOBAL OVARIAN CANCER TESTING MARKET SIZE, BY TYPE,

2014-2021 (USD MILLION) 72

TABLE 19 GLOBAL OVARIAN CANCER TESTING MARKET SIZE, BY COUNTRY,

2014-2021 (USD MILLION) 73

TABLE 20 GLOBAL OVARIAN CANCER TUMOR MARKER TESTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION) 74

TABLE 21 GLOBAL DIAGNOSTIC IMAGING TESTS MARKET SIZE, BY COUNTRY,

2014-2021 (USD MILLION) 75

TABLE 22 GLOBAL OTHER OVARIAN CANCER TESTS MARKET SIZE, BY COUNTRY/REGION, 2014-2021 (USD MILLION) 76

TABLE 23 GLOBAL CERVICAL CANCER TESTING MARKET SIZE, BY TYPE,

2014-2021 (USD MILLION) 77

TABLE 24 GLOBAL CERVICAL CANCER TESTING MARKET SIZE, BY COUNTRY,

2014-2021 (USD MILLION) 78

TABLE 25 GLOBAL PAP SMEAR MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION) 79

TABLE 26 GLOBAL HPV TESTING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION) 80

TABLE 27 GLOBAL PREGNANCY AND FERTILITY TESTING MARKET SIZE, BY TYPE,

2014-2021 (USD MILLION) 81

TABLE 28 GLOBAL PREGNANCY AND FERTILITY TESTING MARKET SIZE, BY COUNTRY,

2014-2021 (USD MILLION) 81

TABLE 29 GLOBAL LAB-BASED TESTING MARKET SIZE, BY COUNTRY,

2014-2021 (USD MILLION) 82

TABLE 30 GLOBAL PREGNANCY AND OVULATION PREDICTION KITS TESTING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION) 83

TABLE 31 GLOBAL FERTILITY MONITORS MARKET SIZE, BY COUNTRY,

2014-2021 (USD MILLION) 85

TABLE 32 GLOBAL PRENATAL GENETIC SCREENING AND CARRIER TESTING MARKET SIZE,

BY TYPE, 2014-2021 (USD MILLION) 86

TABLE 33 GLOBAL PRENATAL GENETIC SCREENING AND CARRIER TESTING MARKET SIZE,

BY COUNTRY, 2014-2021 (USD MILLION) 86

TABLE 34 GLOBAL CYSTIC FIBROSIS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION) 87

TABLE 35 GLOBAL DOWN SYNDROME AND EDWARDS SYNDROME MARKET SIZE,

BY COUNTRY, 2014-2021 (USD MILLION) 88

TABLE 36 GLOBAL TORCH INFECTIONS MARKET SIZE, BY COUNTRY,

2014-2021 (USD MILLION) 89

TABLE 37 GLOBAL OTHER DISEASES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION) 90

TABLE 38 GLOBAL INFECTIOUS DISEASE TESTING MARKET SIZE, BY TYPE,

2014-2021 (USD MILLION) 92

TABLE 39 GLOBAL INFECTIOUS DISEASE TESTING MARKET SIZE, BY COUNTRY,

2014-2021 (USD MILLION) 92

TABLE 40 GLOBAL MRSA TESTING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION) 93

TABLE 41 GLOBAL URINARY TRACT INFECTION TESTING MARKET SIZE, BY COUNTRY,

2014-2021 (USD MILLION) 94

TABLE 42 GLOBAL HEPATITIS TESTING MARKET SIZE, BY COUNTRY,

2014-2021 (USD MILLION) 96

TABLE 43 GLOBAL TUBERCULOSIS TESTING MARKET SIZE, BY COUNTRY,

2014-2021 (USD MILLION) 97

TABLE 44 GLOBAL OTHER INFECTIOUS DISEASE TESTING MARKET SIZE, BY COUNTRY,

2014-2021 (USD MILLION) 98

TABLE 45 GLOBAL SEXUALLY TRANSMITTED DISEASE TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION) 99

TABLE 46 GLOBAL SEXUALLY TRANSMITTED DISEASE TESTING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION) 100

TABLE 47 GLOBAL CT/NG TESTING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION) 101

TABLE 48 GLOBAL HIV TESTING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION) 102

TABLE 49 GLOBAL OTHER SEXUALLY TRANSMITTED DISEASES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION) 103

TABLE 50 GLOBAL ULTRASOUND TESTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION) 104

TABLE 51 GLOBAL ULTRASOUND TESTS MARKET SIZE, BY COUNTRY,

2014-2021 (USD MILLION) 105

TABLE 52 GLOBAL BREAST IMAGING MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION) 106

TABLE 53 GLOBAL OB/GYN MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION) 107

TABLE 54 GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER,

2014–2021 (USD MILLION) 110

TABLE 55 GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE FOR HOSPITALS AND CLINICS, BY COUNTRY, 2014–2021 (USD MILLION) 111

TABLE 56 GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE FOR DIAGNOSTIC AND IMAGING CENTERS, BY COUNTRY, 2014–2021 (USD MILLION) 112

TABLE 57 GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE FOR HOME CARE,

BY COUNTRY, 2014–2021 (USD MILLION) 114

TABLE 58 WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY REGION,

2014–2021 (USD MILLION) 116

TABLE 59 NORTH AMERICA: WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 119

TABLE 60 NORTH AMERICA: WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE,

BY APPLICATION, 2014–2021 (USD MILLION) 119

TABLE 61 NORTH AMERICA: BREAST CANCER TESTING MARKET SIZE, BY TYPE,

2014–2021 (USD MILLION) 120

TABLE 62 NORTH AMERICA: OSTEOPOROSIS TESTING MARKET SIZE, BY TYPE,

2014–2021 (USD MILLION) 120

TABLE 63 NORTH AMERICA: INFECTIOUS DISEASE TESTING MARKET SIZE, BY DISEASE, 2014–2021 (USD MILLION) 121

TABLE 64 NORTH AMERICA: PREGNANCY AND FERTILITY TESTING MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 121

TABLE 65 NORTH AMERICA: ULTRASOUND MARKET SIZE, BY APPLICATION,

2014–2021, (USD MILLION) 122

TABLE 66 NORTH AMERICA: SEXUALLY TRANSMITTED DISEASE TESTING MARKET SIZE,

BY DISEASE TYPE, 2014–2021 (USD MILLION) 122

TABLE 67 NORTH AMERICA: PRENATAL GENETIC AND CARRIER TESTING MARKET SIZE,

BY DISEASE TYPE, 2014–2021, (USD MILLION) 123

TABLE 68 NORTH AMERICA: CERVICAL CANCER TESTING MARKET SIZE, BY TYPE,

2014–2021, (USD MILLION) 123

TABLE 69 NORTH AMERICA: OVARIAN CANCER TESTING MARKET SIZE, BY TYPE,

2014–2021 (USD MILLION) 124

TABLE 70 NORTH AMERICA: WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION) 124

TABLE 71 U.S. : WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION,

2014–2021 (USD MILLION) 125

TABLE 72 U.S. : BREAST CANCER TESTING MARKET SIZE, BY TYPE,

2014–2021 (USD MILLION) 126

TABLE 73 U.S. : OSTEOPOROSIS TESTING MARKET SIZE, BY TYPE,

2014–2021 (USD MILLION) 126

TABLE 74 U.S. : INFECTIOUS DISEASE TESTING MARKET SIZE, BY DISEASE,

2014–2021 (USD MILLION) 127

TABLE 75 U.S. : PREGNANCY AND FERTILITY TESTING MARKET SIZE, BY TYPE,

2014–2021 (USD MILLION) 127

TABLE 76 U.S. : ULTRASOUND MARKET SIZE, BY APPLICATION, 2014–2021, (USD MILLION) 128

TABLE 77 U.S. : SEXUALLY TRANSMITTED DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2014–2021 (USD MILLION) 128

TABLE 78 U.S. : PRENATAL GENETIC AND CARRIER TESTING MARKET SIZE, BY DISEASE TYPE, 2014–2021, (USD MILLION) 129

TABLE 79 U.S. : CERVICAL CANCER TESTING MARKET SIZE, BY TYPE,

2014–2021, (USD MILLION) 129

TABLE 80 U.S. : OVARIAN CANCER TESTING MARKET SIZE, BY TYPE,

2014–2021 (USD MILLION) 130

TABLE 81 U.S. : WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER,

2014–2021 (USD MILLION) 130

TABLE 82 CANADA: WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION,

2014–2021 (USD MILLION) 131

TABLE 83 CANADA: BREAST CANCER TESTING MARKET SIZE, BY TYPE,

2014–2021 (USD MILLION) 132

TABLE 84 CANADA: OSTEOPOROSIS TESTING MARKET SIZE, BY TYPE,

2014–2021 (USD MILLION) 132

TABLE 85 CANADA: INFECTIOUS DISEASE TESTING MARKET SIZE, BY DISEASE,

2014–2021 (USD MILLION) 133

TABLE 86 CANADA : PREGNANCY AND FERTILITY TESTING MARKET SIZE, BY TYPE,

2014–2021 (USD MILLION) 133

TABLE 87 CANADA: ULTRASOUND MARKET SIZE, BY APPLICATION,

2014–2021, (USD MILLION) 134

TABLE 88 CANADA : SEXUALLY TRANSMITTED DISEASE TESTING MARKET SIZE,

BY DISEASE TYPE, 2014–2021 (USD MILLION) 134

TABLE 89 CANADA : PRENATAL GENETIC AND CARRIER TESTING MARKET SIZE,

BY DISEASE TYPE, 2014–2021, (USD MILLION) 135

TABLE 90 CANADA : CERVICAL CANCER TESTING MARKET SIZE, BY TYPE,

2014–2021, (USD MILLION) 135

TABLE 91 CANADA: OVARIAN CANCER TESTING MARKET SIZE, BY TYPE,

2014–2021 (USD MILLION) 136

TABLE 92 CANADA : WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER,

2014–2021 (USD MILLION) 136

TABLE 93 EUROPE: WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY,

2014-2021(USD MILLION) 139

TABLE 94 EUROPE: WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION,

2014-2021 (USD MILLION) 139

TABLE 95 EUROPE: BREAST CANCER TESTING MARKET SIZE, BY TYPE,

2014-2021 (USD MILLION) 140

TABLE 96 EUROPE: OSTEOPOROSIS TESTING MARKET SIZE, BY TYPE,

2014-2021 (USD MILLION) 140

TABLE 97 EUROPE: INFECTIOUS DISEASE TESTING MARKET SIZE, BY DISEASE,

2014-2021 (USD MILLION) 141

TABLE 98 EUROPE: PREGNANCY AND FERTILITY TESTING MARKET SIZE, BY TYPE,

2014-2021 (USD MILLION) 141

TABLE 99 EUROPE: ULTRASOUND MARKET SIZE, BY APPLICATION,

2014-2021 (USD MILLION) 142

TABLE 100 EUROPE: SEXUALLY TRANSMITTED DISEASES MARKET SIZE, BY DISEASE TYPE, 2014-2021 (USD MILLION) 142

TABLE 101 EUROPE: PRENATAL GENETIC AND CARRIER TESTING MARKET SIZE,

BY DISEASE TYPE,2014-2021 (USD MILLION) 143

TABLE 102 EUROPE: CERVICAL CANCER TESTING MARKET SIZE, BY TYPE,

2014-2021 (USD MILLION) 143

TABLE 103 EUROPE: OVARIAN CANCER TESTING MARKET SIZE, BY TYPE,

2014-2021 (USD MILLION) 144

TABLE 104 EUROPE: WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER,

2014-2021 (USD MILLION) 144

TABLE 105 GERMANY : WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION) 146

TABLE 106 GERMANY: BREAST CANCER TESTING MARKET SIZE, BY TYPE,

2014-2021 (USD MILLION) 146

TABLE 107 GERMANY: OSTEOPOROSIS TESTING MARKET SIZE, BY TYPE,

2014-2021 (USD MILLION) 147

TABLE 108 GERMANY: INFECTIOUS DISEASE TESTING MARKET SIZE, BY DISEASE,

2014-2021 (USD MILLION) 147

TABLE 109 GERMANY: PREGNANCY AND FERTILITY TESTING MARKET SIZE, BY TYPE,

2014-2021 (USD MILLION) 148

TABLE 110 GERMANY: ULTRASOUND MARKET SIZE, BY APPLICATION,

2014-2021 (USD MILLION) 148

TABLE 111 GERMANY: SEXUALLY TRANSMITTED DISEASES MARKET SIZE, BY DISEASE TYPE, 2014-2021 (USD MILLION) 149

TABLE 112 GERMANY: PRENATAL GENETIC AND CARRIER TESTING MARKET SIZE,

BY DISEASE TYPE,2014-2021 (USD MILLION) 149

TABLE 113 GERMANY: CERVICAL CANCER TESTING MARKET SIZE, BY TYPE,

2014-2021 (USD MILLION) 150

TABLE 114 GERMANY: OVARIAN CANCER TESTING MARKET SIZE, BY TYPE,

2014-2021 (USD MILLION) 150

TABLE 115 GERMANY: WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER,

2014-2021 (USD MILLION) 151

TABLE 116 U.K.: WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION,

2014-2021 (USD MILLION) 152

TABLE 117 U.K: BREAST CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION) 152

TABLE 118 U.K: OSTEOPOROSIS TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION) 153

TABLE 119 U.K: INFECTIOUS DISEASE TESTING MARKET SIZE, BY DISEASE,

2014-2021 (USD MILLION) 153

TABLE 120 U.K: PREGNANCY AND FERTILITY TESTING MARKET SIZE, BY TYPE,

2014-2021 (USD MILLION) 154

TABLE 121 U.K: ULTRASOUND MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION) 154

TABLE 122 U.K: SEXUALLY TRANSMITTED DISEASES MARKET SIZE, BY DISEASE TYPE,

2014-2021 (USD MILLION) 155

TABLE 123 U.K: PRENATAL GENETIC AND CARRIER TESTING MARKET SIZE, BY DISEASE TYPE, 2014-2021 (USD MILLION) 155

TABLE 124 U.K: CERVICAL CANCER TESTING MARKET SIZE, BY TYPE,

2014-2021 (USD MILLION) 156

TABLE 125 U.K: OVARIAN CANCER TESTING MARKET SIZE, BY TYPE,2014-2021 (USD MILLION) 156

TABLE 126 U.K: WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER,

2014-2021 (USD MILLION) 157

TABLE 127 FRANCE: WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION,

2014-2021 (USD MILLION) 158

TABLE 128 FRANCE: BREAST CANCER TESTING MARKET SIZE, BY TYPE,

2014-2021 (USD MILLION) 158

TABLE 129 FRANCE: OSTEOPOROSIS TESTING MARKET SIZE, BY TYPE,

2014-2021 (USD MILLION) 159

TABLE 130 FRANCE : INFECTIOUS DISEASE TESTING MARKET SIZE, BY DISEASE,

2014-2021 (USD MILLION) 159

TABLE 131 FRANCE: PREGNANCY AND FERTILITY TESTING MARKET SIZE, BY TYPE,

2014-2021 (USD MILLION) 160

TABLE 132 FRANCE: ULTRASOUND MARKET SIZE, BY APPLICATION,

2014-2021 (USD MILLION) 160

TABLE 133 FRANCE: SEXUALLY TRANSMITTED DISEASES MARKET SIZE, BY DISEASE TYPE, 2014-2021 (USD MILLION) 161

TABLE 134 FRANCE: PRENATAL GENETIC AND CARRIER TESTING MARKET SIZE,

BY DISEASE TYPE,2014-2021 (USD MILLION) 161

TABLE 135 FRANCE: CERVICAL CANCER TESTING MARKET SIZE, BY TYPE,

2014-2021 (USD MILLION) 162

TABLE 136 FRANCE: OVARIAN CANCER TESTING MARKET SIZE, BY TYPE,

2014-2021 (USD MILLION) 162

TABLE 137 FRANCE: WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER,

2014-2021 (USD MILLION) 163

TABLE 138 ITALY : WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION,

2014-2021 (USD MILLION) 164

TABLE 139 ITALY: BREAST CANCER TESTING MARKET SIZE, BY TYPE,

2014-2021 (USD MILLION) 164

TABLE 140 ITALY: OSTEOPOROSIS TESTING MARKET SIZE, BY TYPE,

2014-2021 (USD MILLION) 165

TABLE 141 ITALY : INFECTIOUS DISEASE TESTING MARKET SIZE, BY DISEASE,

2014-2021 (USD MILLION) 165

TABLE 142 ITALY: PREGNANCY AND FERTILITY TESTING MARKET SIZE, BY TYPE,

2014-2021 (USD MILLION) 166

TABLE 143 ITALY: ULTRASOUND MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION) 166

TABLE 144 ITALY: SEXUALLY TRANSMITTED DISEASES MARKET SIZE, BY DISEASE TYPE,

2014-2021 (USD MILLION) 167

TABLE 145 ITALY: PRENATAL GENETIC AND CARRIER TESTING MARKET SIZE,

BY DISEASE TYPE, 2014-2021 (USD MILLION) 167

TABLE 146 ITALY: CERVICAL CANCER TESTING MARKET SIZE, BY TYPE,

2014-2021 (USD MILLION) 168

TABLE 147 ITALY: OVARIAN CANCER TESTING MARKET SIZE, BY TYPE,

2014-2021 (USD MILLION) 168

TABLE 148 ITALY: WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER,

2014-2021 (USD MILLION) 169

TABLE 149 SPAIN: WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION,

2014–2021 (USD MILLION) 170

TABLE 150 SPAIN: BREAST CANCER TESTING MARKET SIZE, BY TYPE,

2014–2021 (USD MILLION) 170

TABLE 151 SPAIN: OSTEOPOROSIS TESTING MARKET SIZE, BY TYPE,

2014–2021 (USD MILLION) 171

TABLE 152 SPAIN: INFECTIOUS DISEASE TESTING MARKET SIZE, BY DISEASE,

2014–2021 (USD MILLION) 171

TABLE 153 SPAIN : PREGNANCY AND FERTILITY TESTING MARKET SIZE, BY TYPE,

2014–2021 (USD MILLION) 172

TABLE 154 SPAIN : ULTRASOUND MARKET SIZE, BY APPLICATION,

2014–2021, (USD MILLION) 172

TABLE 155 SPAIN : SEXUALLY TRANSMITTED DISEASE TESTING MARKET SIZE,

BY DISEASE TYPE, 2014–2021 (USD MILLION) 173

TABLE 156 SPAIN : PRENATAL GENETIC AND CARRIER TESTING MARKET SIZE,

BY DISEASE TYPE, 2014–2021, (USD MILLION) 173

TABLE 157 SPAIN : CERVICAL CANCER TESTING MARKET SIZE, BY TYPE,

2014–2021, (USD MILLION) 174

TABLE 158 SPAIN : OVARIAN CANCER TESTING MARKET SIZE, BY TYPE,

2014–2021 (USD MILLION) 174

TABLE 159 SPAIN : WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER,

2014–2021 (USD MILLION) 175

TABLE 160 ROE: WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION,

2014-2021 (USD MILLION) 176

TABLE 161 ROE: BREAST CANCER TESTING MARKET SIZE, BY TYPE,

2014–2021 (USD MILLION) 176

TABLE 162 ROE: OSTEOPOROSIS TESTING MARKET SIZE, BY TYPE,

2014–2021 (USD MILLION) 177

TABLE 163 ROE: INFECTIOUS DISEASE TESTING MARKET SIZE, BY DISEASE,

2014–2021 (USD MILLION) 177

TABLE 164 ROE: PREGNANCY AND FERTILITY TESTING MARKET SIZE, BY TYPE,

2014–2021 (USD MILLION) 178

TABLE 165 ROE: ULTRASOUND MARKET SIZE, BY APPLICATION, 2014–2021, (USD MILLION) 178

TABLE 166 ROE: SEXUALLY TRANSMITTED DISEASE TESTING MARKET SIZE, BY DISEASE TYPE, 2014–2021 (USD MILLION) 179

TABLE 167 ROE: PRENATAL GENETIC AND CARRIER TESTING MARKET SIZE, BY DISEASE TYPE, 2014–2021, (USD MILLION) 179

TABLE 168 ROE: CERVICAL CANCER TESTING MARKET SIZE, BY TYPE,

2014–2021, (USD MILLION) 180

TABLE 169 ROE: OVARIAN CANCER TESTING MARKET SIZE, BY TYPE,

2014–2021 (USD MILLION) 180

TABLE 170 ROE: WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER,

2014–2021 (USD MILLION) 181

TABLE 171 APAC: WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY,

2014–2021(USD MILLION) 183

TABLE 172 APAC: WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION,

2014–2021(USD MILLION) 183

TABLE 173 APAC: BREAST CANCER TESTING, BY TYPE, (USD MILLION) 184

TABLE 174 APAC: OSTEOPOROSIS TESTING, BY TYPE, 2014–2021 (USD MILLION) 184

TABLE 175 APAC: INFECTIOUS DISEASE TESTING MARKET SIZE, BY DISEASE,

2014–2021 (USD MILLION) 185

TABLE 176 APAC: PREGNANCY AND FERTILITY TESTING MARKET SIZE, BY TYPE,

2014–2021 (USD MILLION) 185

TABLE 177 APAC: ULTRASOUND MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION) 186

TABLE 178 APAC: SEXUALLY TRANSMITTED DISEASES MARKET SIZE, BY DISEASE TYPE, 2014–2021 (USD MILLION) 186

TABLE 179 APAC: PRENATAL GENETIC AND CARRIER TESTING MARKET SIZE,

BY DISEASE TYPE, 2014–2021 (USD MILLION) 187

TABLE 180 APAC: CERVICAL CANCER TESTING MARKET SIZE, BY TYPE,

2014–2021 (USD MILLION) 187

TABLE 181 APAC: OVARIAN CANCER MARKET SIZE, BY TESTING, 2014–2021 (USD MILLION) 188

TABLE 182 APAC: WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER,

2014–2021 (USD MILLION) 188

TABLE 183 JAPAN: WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION,

2014–2021(USD MILLION) 189

TABLE 184 JAPAN: BREAST CANCER TESTING, BY TYPE, 2014–2021 (USD MILLION) 190

TABLE 185 JAPAN: OSTEOPOROSIS TESTING, BY TYPE, 2014–2021 (USD MILLION) 190

TABLE 186 JAPAN: INFECTIOUS DISEASE TESTING MARKET SIZE, BY DISEASE,

2014–2021, (USD MILLION) 191

TABLE 187 JAPAN: PREGNANCY AND FERTILITY TESTING MARKET SIZE, BY TYPE,

2014–2021, (USD MILLION) 191

TABLE 188 JAPAN: ULTRASOUND MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION) 192

TABLE 189 JAPAN: SEXUALLY TRANSMITTED DISEASES MARKET SIZE, BY DISEASE TYPE, 2014–2021 (USD MILLION) 192

TABLE 190 JAPAN: PRENATAL GENETIC AND CARRIER TESTING MARKET SIZE,

BY DISEASE TYPE, 2014–2021 (USD MILLION) 193

TABLE 191 JAPAN: CERVICAL CANCER TESTING MARKET SIZE, BY TYPE,

2014–2021 (USD MILLION) 193

TABLE 192 JAPAN: OVARIAN CANCER MARKET SIZE, BY TESTING, 2014–2021 (USD MILLION) 194

TABLE 193 JAPAN: WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER,

2014-2021 (USD MILLION) 194

TABLE 194 CHINA: WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION,

2014–2021 (USD MILLION) 195

TABLE 195 CHINA: BREAST CANCER TESTING MARKET SIZE, BY TYPE,

2014–2021 (USD MILLION) 196

TABLE 196 CHINA: OSTEOPOROSIS TESTING MARKET SIZE, BY TYPE,

2014–2021 (USD MILLION) 196

TABLE 197 CHINA: INFECTIOUS DISEASE TESTING MARKET SIZE, BY DISEASE,

2014–2021 (USD MILLION) 197

TABLE 198 CHINA: PREGNANCY AND FERTILITY TESTING MARKET SIZE, BY TYPE,

2014–2021 (USD MILLION) 197

TABLE 199 CHINA: ULTRASOUND MARKET SIZE, BY APPLICATION, 2014–2021, (USD MILLION) 198

TABLE 200 CHINA: SEXUALLY TRANSMITTED DISEASE TESTING MARKET SIZE,

BY DISEASE TYPE, 2014–2021 (USD MILLION) 198

TABLE 201 CHINA: PRENATAL GENETIC AND CARRIER TESTING MARKET SIZE,

BY DISEASE TYPE, 2014–2021, (USD MILLION) 199

TABLE 202 CHINA: CERVICAL CANCER TESTING MARKET SIZE, BY TYPE,

2014–2021, (USD MILLION) 199

TABLE 203 CHINA: OVARIAN CANCER TESTING MARKET SIZE, BY TYPE,

2014–2021 (USD MILLION) 200

TABLE 204 CHINA: WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER,

2014–2021 (USD MILLION) 200

TABLE 205 INDIA: WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION,

2014–2021(USD MILLION) 201

TABLE 206 INDIA: BREAST CANCER TESTING, BY TYPE, 2014–2021 (USD MILLION) 202

TABLE 207 INDIA: OSTEOPOROSIS TESTING, BY TYPE, 2014–2021 (USD MILLION) 202

TABLE 208 INDIA: INFECTIOUS DISEASE TESTING MARKET SIZE, BY DISEASE,

2014–2021 (USD MILLION) 203

TABLE 209 INDIA: PREGNANCY AND FERTILITY TESTING MARKET SIZE, BY TYPE,

2014–2021 (USD MILLION) 203

TABLE 210 INDIA: ULTRASOUND MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION) 204

TABLE 211 INDIA: SEXUALLY TRANSMITTED DISEASES MARKET SIZE, BY DISEASE TYPE, 2014–2021 (USD MILLION) 204

TABLE 212 INDIA: PRENATAL GENETIC AND CARRIER TESTING MARKET SIZE,

BY DISEASE TYPE, 2014–2021, (USD MILLION) 205

TABLE 213 INDIA: CERVICAL CANCER TESTING MARKET SIZE, BY TYPE,

2014–2021 (USD MILLION) 205

TABLE 214 INDIA: OVARIAN CANCER MARKET SIZE, BY TESTING, 2014–2021 (USD MILLION) 206

TABLE 215 INDIA: WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER,

2014–2021 (USD MILLION) 206

TABLE 216 ROAPAC: WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION,

2014–2021(USD MILLION) 207

TABLE 217 ROAPAC: BREAST CANCER TESTING, BY TYPE, (USD MILLION) 208

TABLE 218 ROAPAC: OSTEOPOROSIS TESTING, BY TYPE, 2014–2021 (USD MILLION) 208

TABLE 219 ROAPAC: INFECTIOUS DISEASE TESTING MARKET SIZE, BY DISEASE,

2014–2021 (USD MILLION) 209

TABLE 220 ROAPAC: PREGNANCY AND FERTILITY TESTING MARKET SIZE, BY TYPE,

2014–2021, (USD MILLION) 209

TABLE 221 ROAPAC: ULTRASOUND MARKET SIZE, BY APPLICATION,

2014–2021 (USD MILLION) 210

TABLE 222 ROAPAC: SEXUALLY TRANSMITTED DISEASES MARKET SIZE, BY DISEASE TYPE, 2014–2021 (USD MILLION) 210

TABLE 223 ROAPAC: PRENATAL GENETIC AND CARRIER TESTING MARKET SIZE,

BY DISEASE TYPE, 2014–2021 (USD MILLION) 211

TABLE 224 ROAPAC: CERVICAL CANCER TESTING MARKET SIZE, BY TYPE,

2014–2021 (USD MILLION) 211

TABLE 225 ROAPAC: OVARIAN CANCER MARKET SIZE, BY TESTING,

2014–2021, (USD MILLION) 212

TABLE 226 ROAPAC: WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE,

BY END USER (USD MILLION) 212

TABLE 227 ROW: WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY COUNTRY,

2014–2021 (USD MILLION) 213

TABLE 228 ROW: WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION,

2014–2021 (USD MILLION) 214

TABLE 229 ROW: BREAST CANCER TESTING MARKET SIZE, BY TYPE,

2014–2021 (USD MILLION) 214

TABLE 230 ROW: OSTEOPOROSIS TESTING MARKET SIZE, BY TYPE,

2014–2021 (USD MILLION) 215

TABLE 231 ROW: INFECTIOUS DISEASE TESTING MARKET SIZE, BY DISEASE,

2014–2021 (USD MILLION) 215

TABLE 232 ROW: PREGNANCY AND FERTILITY TESTING MARKET SIZE, BY TYPE,

2014–2021 (USD MILLION) 216

TABLE 233 ROW: ULTRASOUND MARKET SIZE, BY APPLICATION, 2014–2021, (USD MILLION) 216

TABLE 234 ROW: SEXUALLY TRANSMITTED DISEASE TESTING MARKET SIZE,

BY DISEASE TYPE, 2014–2021 (USD MILLION) 217

TABLE 235 ROW: PRENATAL GENETIC AND CARRIER TESTING MARKET SIZE,

BY DISEASE TYPE, 2014–2021, (USD MILLION) 217

TABLE 236 ROW: CERVICAL CANCER TESTING MARKET SIZE, BY TYPE,

2014–2021, (USD MILLION) 218

TABLE 237 ROW: OVARIAN CANCER TESTING MARKET SIZE, BY TYPE,

2014–2021 (USD MILLION) 218

TABLE 238 ROW: WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER,

2014–2021 (USD MILLION) 219

TABLE 239 LATIN AMERICA: WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION) 220

TABLE 240 LATIN AMERICA: BREAST CANCER TESTING MARKET SIZE, BY TYPE,

2014–2021 (USD MILLION) 220

TABLE 241 LATIN AMERICA: OSTEOPOROSIS TESTING MARKET SIZE, BY TYPE,

2014–2021 (USD MILLION) 221

TABLE 242 LATIN AMERICA: INFECTIOUS DISEASE TESTING MARKET SIZE, BY DISEASE,

2014–2021 (USD MILLION) 221

TABLE 243 LATIN AMERICA: PREGNANCY AND FERTILITY TESTING MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 222

TABLE 244 LATIN AMERICA: ULTRASOUND MARKET SIZE, BY APPLICATION,

2014–2021, (USD MILLION) 222

TABLE 245 LATIN AMERICA: SEXUALLY TRANSMITTED DISEASE TESTING MARKET SIZE,

BY DISEASE TYPE, 2014–2021 (USD MILLION) 223

TABLE 246 LATIN AMERICA: PRENATAL GENETIC AND CARRIER TESTING MARKET SIZE,

BY DISEASE TYPE, 2014–2021, (USD MILLION) 223

TABLE 247 LATIN AMERICA: CERVICAL CANCER TESTING MARKET SIZE, BY TYPE,

2014–2021, (USD MILLION) 224

TABLE 248 LATIN AMERICA: OVARIAN CANCER TESTING MARKET SIZE, BY TYPE,

2014–2021 (USD MILLION) 224

TABLE 249 LATIN AMERICA: WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE, BY END USER, 2014–2021 (USD MILLION) 225

TABLE 250 MIDDLE EAST & AFRICA: WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE,

BY APPLICATION, 2014-2021 (USD MILLION) 226

TABLE 251 MIDDLE EAST & AFRICA: BREAST CANCER TESTING MARKET SIZE, BY TYPE,

2014-2021 (USD MILLION) 226

TABLE 252 MIDDLE EAST & AFRICA: OSTEOPOROSIS TESTING MARKET SIZE, BY TYPE,

2014-2021 (USD MILLION) 227

TABLE 253 MIDDLE EAST & AFRICA: INFECTIOUS DISEASE TESTING MARKET SIZE,

BY DISEASE, 2014-2021 (USD MILLION) 227

TABLE 254 MIDDLE EAST & AFRICA: PREGNANCY AND FERTILITY TESTING MARKET SIZE,

BY TYPE, 2014-2021 (USD MILLION) 228

TABLE 255 MIDDLE EAST & AFRICA: ULTRASOUND MARKET SIZE, BY APPLICATION,

2014-2021 (USD MILLION) 228

TABLE 256 MIDDLE EAST & AFRICA: SEXUALLY TRANSMITTED DISEASES MARKET SIZE,

BY DISEASE TYPE, 2014-2021 (USD MILLION) 229

TABLE 257 MIDDLE EAST & AFRICA: PRENATAL GENETIC AND CARRIER TESTING MARKET SIZE, BY DISEASE TYPE, 2014-2021 (USD MILLION) 229

TABLE 258 MIDDLE EAST & AFRICA: CERVICAL CANCER TESTING MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION) 230

TABLE 259 MIDDLE EAST & AFRICA: OVARIAN CANCER MARKET SIZE, BY TYPE,

2014-2021 (USD MILLION) 230

TABLE 260 MIDDLE EAST & AFRICA: WOMEN’S HEALTH DIAGNOSTICS MARKET SIZE,

BY END USER, 2014-2021 (USD MILLION) 231

TABLE 261 GROWTH STRATEGY MATRIX (2013–2016) 233

TABLE 262 PRODUCT LAUNCHES, 2013–2016 237

TABLE 263 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2013–2016 238

TABLE 264 ACQUISITIONS, 2013–2016 239

TABLE 265 REGULATORY APPROVALS, 2013–2016 240

List Of Figures, Charts and Diagrams
in Women's Health Diagnostics Market by Application (Prenatal Testing, Down Syndrome, HPV, Fertility Test, Pregnancy Test, Urinary Tract Infections, Osteoporosis, Breast, Cervical and Ovarian Cancer Test) End User (Hospitals, Home Care) - Forecast to 2021 [Published by MarketsandMarkets]

LIST OF FIGURES


FIGURE 1 GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET 23

FIGURE 2 RESEARCH DESIGN 26

FIGURE 3 BOTTOM-UP APPROACH 30

FIGURE 4 TOP-DOWN APPROACH 31

FIGURE 5 DATA TRIANGULATION METHODOLOGY 32

FIGURE 6 WOMEN’S HEALTH DIAGNOSTICS MARKET, BY APPLICATION, 2016 VS. 2021 34

FIGURE 7 WOMEN’S HEALTH DIAGNOSTICS MARKET, BY END USER, 2016 VS. 2021 35

FIGURE 8 GEOGRAPHIC SNAPSHOT: WOMEN’S HEALTH DIAGNOSTICS MARKET 36

FIGURE 9 HIGH PREVALENCE OF INFECTIOUS DISEASES IN WOMEN AND RISING INCIDENCE OF CHRONIC AND LIFESTYLE-RELATED DISORDERS IN WOMEN ARE DRIVING GROWTH IN THE WOMEN’S HEALTH DIAGNOSTICS MARKET 37

FIGURE 10 PREGNANCY TESTING AND OVULATION PREDICTION KITS SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA-PACIFIC PREGNANCY AND FERTILITY TESTING MARKET IN 2015 38

FIGURE 11 THE U.S. COMMANDED THE LARGEST SHARE OF THE WOMEN’S HEALTH DIAGNOSTICS MARKET IN 2015 39

FIGURE 12 APAC TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 40

FIGURE 13 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING THE FORECAST PERIOD 41

FIGURE 14 WOMEN’S HEALTH DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 44

FIGURE 15 CLINICAL STUDIES FOR BREAST CANCER DIAGNOSTIC DEVICES (2013-2016) 56

FIGURE 16 BREAST CANCER SEGMENT TO DOMINATE THE MARKET IN 2016 60

FIGURE 17 MAMMOGRAPHY SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD 65

FIGURE 18 URINARY TRACT INFECTIONS TESTING SEGMENT TO DOMINATE

THE MARKET IN 2016 91

FIGURE 19 THE HOSPITALS & CLINICS END-USER SEGMENT WILL CONTINUE TO DOMINATE THE GLOBAL WOMEN’S HEALTH DIAGNOSTICS MARKET IN 2021 109

FIGURE 20 NORTH AMERICA:WOMEN’S HEALTH DIAGNOSTICS MARKET SNAPSHOT 118

FIGURE 21 EUROPE:WOMEN’S HEALTH DIAGNOSTICS MARKET SNAPSHOT 138

FIGURE 22 ASIA-PACIFIC: WOMEN’S HEALTH DIAGNOSTICS MARKET SNAPSHOT 182

FIGURE 23 PRODUCT LAUNCH—KEY GROWTH STRATEGY ADOPTED BY MARKET PLAYERS FROM 2013 TO SEPTEMBER 2016 232

FIGURE 24 LIST OF NEW PRODUCT LAUNCHES BY KEY PLAYERS IN THE MARKET FROM

2014 - 2016 234

FIGURE 25 KEY ACQUISITIONS: WOMEN’S HEALTH DIAGNOSTICS MARKET (2014–2016) 235

FIGURE 26 BATTLE FOR MARKET SHARE: PRODUCT LAUNCH ACCOUNTED FOR THE LARGEST SHARE DURING 2013 TO 2016 236

FIGURE 27 COMPANY SNAPSHOT: SIEMENS AG 241

FIGURE 28 COMPANY SNAPSHOT: QUEST DIAGNOSTICS INC. 245

FIGURE 29 COMPANY SNAPSHOT: HOLOGIC, INC. 253

FIGURE 30 COMPANY SNAPSHOT: F. HOFFMANN-LA ROCHE AG 258

FIGURE 31 COMPANY SNAPSHOT: PERKINELMER INC. 262

FIGURE 32 COMPANY SNAPSHOT: ALERE INC. 264

FIGURE 33 COMPANY SNAPSHOT: GE HEALTHCARE 266

FIGURE 34 COMPANY SNAPSHOT: BECTON, DICKINSON AND COMPANY 269

FIGURE 35 COMPANY SNAPSHOT: ABBOTT LABORATORIES 271

FIGURE 36 COMPANY SNAPSHOT: BIOMÉRIEUX SA 274

FIGURE 37 COMPANY SNAPSHOT: KONINKLIJKE PHILIPS N.V. 276

Additional Details

Publisher

MarketsandMarkets

Publisher Information

Reference

25799 | MD 4774

Number of Pages

296

Report Format

PDF

MarketsandMarkets Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Global and Chinese Womens shoes Industry, 2017 Market Research Report
The 'Global and Chinese Womens shoes Industry, 2012-2022 Market Research Report' is a professional a...
15 Dec 2017 by Prof Research USD $3,000 More Info
Global and Chinese Womens Putters Industry, 2017 Market Research Report
The 'Global and Chinese Womens Putters Industry, 2012-2022 Market Research Report' is a professional...
15 Dec 2017 by Prof Research USD $3,000 More Info
Global and Chinese Womens Hybrid Golf Clubs Industry, 2017 Market Research Report
The 'Global and Chinese Womens Hybrid Golf Clubs Industry, 2012-2022 Market Research Report' is a pr...
15 Dec 2017 by Prof Research USD $3,000 More Info
Global and Chinese Womens Headbands Industry, 2017 Market Research Report
The 'Global and Chinese Womens Headbands Industry, 2012-2022 Market Research Report' is a profession...
15 Dec 2017 by Prof Research USD $3,000 More Info
Global and Chinese Womens Golf Wedges Industry, 2017 Market Research Report
The 'Global and Chinese Womens Golf Wedges Industry, 2012-2022 Market Research Report' is a professi...
15 Dec 2017 by Prof Research USD $3,000 More Info
Global and Chinese Womens Golf Shoes Industry, 2017 Market Research Report
The 'Global and Chinese Womens Golf Shoes Industry, 2012-2022 Market Research Report' is a professio...
15 Dec 2017 by Prof Research USD $3,000 More Info
Global and Chinese Womens Golf Drivers Industry, 2017 Market Research Report
The 'Global and Chinese Womens Golf Drivers Industry, 2012-2022 Market Research Report' is a profess...
15 Dec 2017 by Prof Research USD $3,000 More Info
Global and Chinese Womens Golf Club Sets Industry, 2017 Market Research Report
The 'Global and Chinese Womens Golf Club Sets Industry, 2012-2022 Market Research Report' is a profe...
15 Dec 2017 by Prof Research USD $3,000 More Info
Global and Chinese Womens Fleece Jackets Industry, 2017 Market Research Report
The 'Global and Chinese Womens Fleece Jackets Industry, 2012-2022 Market Research Report' is a profe...
15 Dec 2017 by Prof Research USD $3,000 More Info
Global and Chinese Womens Fairway Woods Industry, 2017 Market Research Report
The 'Global and Chinese Womens Fairway Woods Industry, 2012-2022 Market Research Report' is a profes...
15 Dec 2017 by Prof Research USD $3,000 More Info

This report is published by MarketsandMarkets

Download Free Report Summary PDF

Women's Health Diagnostics Market by Application (Prenatal Testing, Down Syndrome, HPV, Fertility Test, Pregnancy Test, Urinary Tract Infections, Osteoporosis, Breast, Cervical and Ovarian Cancer Test) End User (Hospitals, Home Care) - Forecast to 2021 [Published by MarketsandMarkets] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...